With a commitment to enhancing patient well-being, Synvisc products utilise advanced hyaluronic acid technology derived from rooster combs to replicate the natural lubricating properties of synovial fluid. Backed by extensive clinical research and a wealth of publications, Synvisc has transformed the lives of millions by providing lasting pain relief and improved mobility.
Buy Synvisc online for fast-acting relief from osteoarthritis pain. Improve mobility and delay the need for surgery with this injectable treatment.
The Synvisc products are designed to mimic the synovial fluid naturally found in joints, effectively addressing the symptoms of osteoarthritis and improving the quality of life for millions of patients worldwide. Synvisc injection specifically relieves pain and enhances mobility in individuals suffering from osteoarthritis. Made from hylan polymers derived from rooster combs, this injectable gel replicates the properties of natural synovial fluid, which lubricates and cushions joints.
When injected into the knee joint, Synvisc serves as a cushion and lubricant, reducing friction between bones, alleviating pain, and improving joint function. It is particularly beneficial for patients who have not found sufficient relief from other conservative treatments, such as physical therapy or pain medications.
With over 300 published studies involving clinical trials on 13 million knees globally, these innovative treatments have proven their efficacy. Thanks to the unique cross-linking hyaluronic acid gel, patients can experience up to 6 months of pain-free mobility, allowing for further treatment enhancements as needed.
Synvisc is FDA-approved for the treatment of osteoarthritis knee pain in patients who have not responded adequately to conservative non-pharmacologic therapies and simple analgesics, such as acetaminophen. It provides pain relief and improves joint function.
Synvisc products are manufactured by Genzyme Corporation, based in New Jersey.
Synvisc products consists of hydrated hylan A and B polymers sourced from rooster combs. These polymers undergo chemical cross-linking to enhance viscosity and elasticity, resulting in a viscoelastic injectable gel that closely mimics natural synovial fluid. Each syringe contains hylan, as well as sodium chloride, disodium hydrogen phosphate, sodium dihydrogen phosphate hydrate, and sterile water for injection, ensuring a formulation that effectively replicates the properties of synovial fluid.
Synvisc products are administered by intra-articular injection into the knee once a week for a total of 3 injections. A strict aseptic technique must be followed. Key administration steps include:
Synvisc has not been tested for use in joints other than the knee.
Synvisc and Synvisc One are injectable treatments designed to relieve pain and improve mobility for individuals with osteoarthritis. Both Synvisc products offer similar benefits, the only difference is that Synvisc One is provided with one injection, compared to the three injections required for Synvisc.
Synvisc injections can provide effects lasting up to 6 months, until the hylan gel is metabolized by the body. It’s important to note that the duration of relief may vary between individuals.
Before treatment, the patient needs to review their medical history with the treatment provider to ensure that Synvisc is a suitable option.
Following the injection, it is advisable to avoid strenuous activities, such as high-impact sports (e.g., soccer, tennis, jogging), and prolonged weight-bearing activities for approximately 48 hours.
Patients may experience pain, swelling, or effusion in the joint following the injection. While these reactions are generally mild and temporary, if swelling or pain becomes severe, it is important to consult a doctor.
If there’s extensive swelling or significant discomfort, recommended treatment may involve rest, ice application, or pain relievers.
Patients should be aware that allergic reactions can occur, which is why it is crucial to inform a healthcare provider of any previous adverse reactions to hyaluronan products. If any severe symptoms arise post-injection, prompt medical attention is advised.
Synvisc products should not be given to patients who have a known hypersensitivity or allergy to hyaluronan or sodium hyaluronate products, or a knee joint infections (or other skin conditions) at the injection site.
The safety and effectiveness of Synvisc injections have not been established in pregnant or breastfeeding women, nor in individuals under 21 years of age.
If you are a licensed medical professional, orthopedic specialist, or clinic seeking to purchase Synvisc products, you can find them through authorised distributors or medical supply stores. To ensure product authenticity and quality, it’s essential to buy Synvisc products from reputable medical suppliers, such as Best Buy Fillers, which offers a range of top-quality orthopedic injectables for professional use.
The key difference between Durolane and Synvisc lies in their injection schedule and duration. Durolane typically requires a single injection that can last up to six months, while Synvisc may need a series of three to five injections. Both use hyaluronic acid to relieve osteoarthritis pain and improve mobility.
Synvisc is covered by Medicare and most insurance plans.
The cost of Synvisc can vary depending on the location, healthcare provider, and whether you have insurance coverage. On average, the price ranges between $340 to $1,200 per injection. It’s best to consult your healthcare provider or pharmacy for the most accurate pricing based on your situation.
Synvisc injections can be repeated, but the frequency depends on your individual condition and your doctor’s recommendation. Typically, treatments can be administered every six months or when knee pain from osteoarthritis returns. Always consult your healthcare provider for the best schedule.
Some patients may experience knee pain relief from osteoarthritis after the first injection, but it’s essential to complete all three injections for the best results. While responses vary, most patients notice significant relief within 8 to 12 weeks of the initial injection.
Join our newsletter to receive latest news and offers
Medicle MD Ltd
Reg. Number: 14317237
Address: 27 Old Gloucester Street,
WC1N 3AX London,
United Kingdom
